TY - JOUR
T1 - Child COVID-19 vaccine uptake among participants of the 2015 Pelotas (Brazil) Birth Cohort Study
AU - Sartori, Ana Lucia
AU - Buffarini, Romina
AU - Machado da Silva, Aline
AU - Amaral de Andrade Leão, Otávio
AU - Ramos Flores, Thaynã
AU - Dâmaso Bertoldi, Andréa
AU - Curi Hallal, Pedro
AU - Freitas da Silveira, Mariângela
N1 - Publisher Copyright:
© 2024
PY - 2024
Y1 - 2024
N2 - Objective: To analyze COVID-19 vaccine uptake in children and to investigate factors associated with two outcomes variables: (a) not even beginning; (b) not completing the COVID-19 vaccine series. Methods: We used data of children aged 6–7 years from the 2015 Pelotas c Birth Cohort Study. COVID-19 vaccination status was collected from immunization cards and National Immunization Program Information System. Adjusted analyses were performed using a hierarchical model to identify factors associated with the two study outcomes. Results: Among 3867 children, 20.7 % (95 % CI, 19.5 %–22.0 %) did not even begin the 2-dose primary COVID-19 vaccine series, and 28.2 % (95 % CI, 26.6 %–29.8 %) did not complete the series with the second dose. Children not even beginning the COVID-19 vaccine series were more likely to have a White mother, not to have obesity, to have a history of COVID-19 infection, to have received non-recommended drugs for COVID-19, to be afraid of needles, and to have an incomplete diphtheria-tetanus-pertussis (DTP) and poliovirus immunization schedule. Not completing the 2-dose series was associated with lower maternal age and education, mother's self-identification as White or Brown, lower household income, lack of access to health services, not having completed the DTP and poliovirus immunization schedule and living with a person with a history of infection with COVID-19. Conclusion: The results highlight a vaccine-hesitant parents’ group who chose not beginning the COVID-19 vaccine series of their children and, another group of parents who failure to complete the child's series due to difficulty accessing health services.
AB - Objective: To analyze COVID-19 vaccine uptake in children and to investigate factors associated with two outcomes variables: (a) not even beginning; (b) not completing the COVID-19 vaccine series. Methods: We used data of children aged 6–7 years from the 2015 Pelotas c Birth Cohort Study. COVID-19 vaccination status was collected from immunization cards and National Immunization Program Information System. Adjusted analyses were performed using a hierarchical model to identify factors associated with the two study outcomes. Results: Among 3867 children, 20.7 % (95 % CI, 19.5 %–22.0 %) did not even begin the 2-dose primary COVID-19 vaccine series, and 28.2 % (95 % CI, 26.6 %–29.8 %) did not complete the series with the second dose. Children not even beginning the COVID-19 vaccine series were more likely to have a White mother, not to have obesity, to have a history of COVID-19 infection, to have received non-recommended drugs for COVID-19, to be afraid of needles, and to have an incomplete diphtheria-tetanus-pertussis (DTP) and poliovirus immunization schedule. Not completing the 2-dose series was associated with lower maternal age and education, mother's self-identification as White or Brown, lower household income, lack of access to health services, not having completed the DTP and poliovirus immunization schedule and living with a person with a history of infection with COVID-19. Conclusion: The results highlight a vaccine-hesitant parents’ group who chose not beginning the COVID-19 vaccine series of their children and, another group of parents who failure to complete the child's series due to difficulty accessing health services.
KW - COVID-19
KW - Immunization coverage
KW - SARS-CoV-2 vaccine
KW - Vaccination hesitancy
KW - Vaccination, Cohort studies
KW - Vaccine pediatric cohort
UR - http://www.scopus.com/inward/record.url?scp=85198137991&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85198137991&partnerID=8YFLogxK
U2 - 10.1016/j.vaccine.2024.07.006
DO - 10.1016/j.vaccine.2024.07.006
M3 - Article
C2 - 38991916
AN - SCOPUS:85198137991
SN - 0264-410X
JO - Vaccine
JF - Vaccine
ER -